治療薬モニタリングの世界市場：製品（消耗品、装置）、技術（イムノアッセイ、プロテオミクス技術）...市場調査レポートについてご紹介

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.2.1 Key Industry Insights
2.2.3 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 30)
4.1 Therapeutic Drug Monitoring: Market Overview
4.2 Geographical Analysis: Market, By Classes of Drug (2015)
4.3 Geographical Snapshot of the Market, 2015
4.4 Market, By Technology
4.5 Its Equipment Market, By Type

5 Market Overview (Page No. – 34)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.4 Drivers
5.4.1 Advances in Drug Pharmacokinetics and Pharmacogenetics to Increase the Demand for Therapeutics Drug Monitoring
5.4.2 Use of TDM in Traditional Anticancer Therapies
5.5 Restraints
5.5.1 Lack of Financial Provision for Clinical Interpretation of TDM Results
5.6 Opportunities
5.6.1 Enabling Personalized Medicine Via Therapeutic Drug Monitoring While Reducing Healthcare Costs
5.7 Challenges
5.7.1 Dearth of Skilled Professionals to Perform Tests and Interpret Results

6 Therapeutic Drug Monitoring Market, By Product (Page No. – 39)
6.1 Introduction
6.2 Consumables
6.3 Equipment
6.3.1 Immunoassay Analyzers
6.3.2 Proteomics Equipment
6.3.3 Other Equipment

7 Therapeutic Drug Monitoring Market, By Technology (Page No. – 48)
7.1 Introduction
7.2 Immunoassays
7.2.1 Chemiluminescent Immunoassay (CLIA)
7.2.2 Cloned Enzyme Donor Immunoassay (CEDIA)
7.2.3 Fluorescence Polarization Immunoassay (FPIA)
7.2.4 Particle-Enhanced Turbidimetric-Inhibition Immunoassay (PETININA)
7.3 Proteomic Technologies
7.3.1 Liquid Chromatography/Mass Spectrometry (LC-MS)
7.3.2 Gas Chromatography/Mass Spectrometry (GC-MS)
7.4 Other Technologies

8 Therapeutic Drug Monitoring Market, By Class of Drug (Page No. – 60)
8.1 Introduction
8.2 Antiepileptics
8.3 Antiarrhythmic Drugs
8.4 Immunosuppressants
8.5 Antibiotics
8.6 Bronchodilators
8.7 Psychoactive Drugs
8.8 Other Drug Classes

9 Therapeutic Drug Monitoring Market, By End User (Page No. – 72)
9.1 Introduction
9.2 Hospital Labs
9.3 Commercial/Private Labs
9.4 Other End Users

10 Global Therapeutic Drug Monitoring Market, By Region (Page No. – 77)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia-Pacific
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 105)
11.1 Overview
11.2 Competitive Situation and Trends
11.2.1 New Product Launches, Product Approvals, and Patents
11.2.2 Acquisitions
11.2.3 Marketing and Promotions
11.2.4 Agreements
11.2.5 Others

12 Company Profiles (Page No. – 111)
(Overview, Financials, Products & Services, Strategy, & Developments)*
12.1 Introduction
12.2 Roche Diagnostics
12.3 Siemens Healthcare
12.4 Thermo Fisher Scientific, Inc.
12.5 Danaher Corporation
12.6 Bio-Rad Laboratories, Inc.
12.7 Abbott Laboratories
12.8 Agilent Technologies
12.9 Biomérieux
12.10 Alere Inc.
12.11 Sekisui Medical Co. Ltd.

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 133)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports